Trials / Conditions / Clear Cell Carcinoma

Clear Cell Carcinoma

10 registered clinical trials studyying Clear Cell Carcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Trea NCT07072234	M.D. Anderson Cancer Center	Phase 1
Recruiting	A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Plati NCT05460000	North Eastern German Society of Gynaecological Oncology	Phase 2
Recruiting	A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy NCT06023862	Yonsei University	Phase 2
Active Not Recruiting	A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies NCT05032040	Xencor, Inc.	Phase 2
Completed	Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. NCT04458597	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Completed	Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ova NCT04227522	North Eastern German Society of Gynaecological Oncology	Phase 3
Recruiting	An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Bi NCT04623502	University of Texas Southwestern Medical Center	N/A
Completed	A Study of Nivolumab in Selected Uterine Cancer Patients NCT03241745	Memorial Sloan Kettering Cancer Center	Phase 2
Withdrawn	Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) NCT01732432	University Hospital, Basel, Switzerland	—
Completed	A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory S NCT01625351	St. Jude Children's Research Hospital	Phase 1